TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques. - Wikidata - wikimedia - TriplyDB

TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques.

TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques.

http://www.wikidata.org/entity/Q37166308

about

Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis Toll-like Receptors in the Vascular System: Sensing the Dangers Within.Hyperglycemia Suppresses Calcium Phosphate-Induced Aneurysm Formation Through Inhibition of Macrophage Activation Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.Activation of Toll-like receptor 3 increases mouse aortic vascular smooth muscle cell contractility through ERK1/2 pathway.Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets.

P2860

Q33678336-5F0123F3-E82D-4901-BFD2-C11D3B2361F4 Q36453194-0003D120-EFEA-424A-ACBA-5C9D488A3D17 Q37090851-B0A97994-A6A0-4075-8BCF-D403062B3AE0 Q38557048-2445F50A-B76B-4AE4-B66E-E72BEBA34896 Q41337363-7D0040AB-DA52-4AC2-87A9-57E44032DFC8 Q42329957-8FDE2A66-2584-4340-BB6C-B52466A0358A Q55407912-06B9C280-09AC-4F86-80B9-2A99C753A756

P2860

TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques.

http://www.wikidata.org/entity/Q37166308

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

TLR3 deficiency protects again ...... urine atherosclerotic plaques.

@en

TLR3 deficiency protects again ...... urine atherosclerotic plaques.

@nl

type

label

TLR3 deficiency protects again ...... urine atherosclerotic plaques.

@en

TLR3 deficiency protects again ...... urine atherosclerotic plaques.

@nl

prefLabel

TLR3 deficiency protects again ...... urine atherosclerotic plaques.

@en

TLR3 deficiency protects again ...... urine atherosclerotic plaques.

@nl

P1433

Q37166308-000AB77A-9A4D-4A1E-951F-740C5A07AFA5

P1476

Q37166308-A001AE74-0030-4BB7-BCFF-882119C1CFC4

P2093

Q37166308-3CF5198E-2C31-4DC0-A35B-7641071D5212

Q37166308-6397B6CD-3BD4-483E-B17D-477A7354FB26

Q37166308-B238909A-6513-4E5C-8861-5CC86FE9F193

Q37166308-B6C7490B-760B-40C9-A6A0-152729485A41

Q37166308-C52334A2-4AD7-47FF-BE07-186494D9E132

P2860

Q37166308-08CA6CCD-9622-43B9-ACE2-25A030CBE5DF

Q37166308-0ECC925B-BC2F-4C4F-B524-ACB5D20C54A6

Q37166308-10287AED-5C74-4F89-A1F0-7746DE69C61C

Q37166308-11175843-4358-4BC6-A833-486FACB298D1

Q37166308-1A17CAEC-4D84-4BEC-95A6-253C894AF68E

Q37166308-29B874DB-09E6-4542-90FA-82D208FF5627

Q37166308-2A2500C1-E210-4DC7-880B-27BC2AA7CC63

Q37166308-3F70668D-B68C-4067-9DE6-99E5131F360B

Q37166308-46599AF8-29AB-42FA-83D8-3BC9EF248B32

Q37166308-516637F8-A7CB-4774-AE52-EE0A3D923021

P304

Q37166308-BF32A22F-512A-4965-8579-AF6F7E790156

P31

Q37166308-1A4EC3E2-1003-4EEF-A07E-6C174BBE9BCA

P356

Q37166308-568D1117-7277-4E8F-9603-C7A2B9B5EE85

P433

Q37166308-2265F33A-EAA1-424E-91A4-5A8B71394B6F

P478

Q37166308-B191E6A1-8D85-4E04-AEE2-A671DADF2BA8

P577

Q37166308-1ADE7B38-EE02-4E1D-B50E-EF768CD213D3

P698

Q37166308-BF7D0E59-6688-4330-A7F9-74CCDD1C6B23

P921

Q37166308-D27E3CC7-FEAB-4501-A73F-D50595AD834D

Q37166308-F071CEBE-3E38-45D4-BE26-F1AE556D749B

P932

Q37166308-0292FF58-F279-4A92-9A5D-A69A0C72F244

P356

J.ATHEROSCLEROSIS.2013.03.035

P1433

Atherosclerosis

P1476

TLR3 deficiency protects again ...... urine atherosclerotic plaques.

@en

P2093

Alan R Tall

http://www.w3.org/2001/XMLSchema#string

Carrie L Welch

http://www.w3.org/2001/XMLSchema#string

Jeanine M D'Armiento

http://www.w3.org/2001/XMLSchema#string

Minako Ishibashi

http://www.w3.org/2001/XMLSchema#string

Scott Sayers

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

Unexpected protective role for Toll-like receptor 3 in the arterial wall

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease.

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

COL4A1 is associated with arterial stiffness by genome-wide association scan.

Modulation of atherosclerosis in mice by Toll-like receptor 2

Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.

P304

52-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ATHEROSCLEROSIS.2013.03.035

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

229

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23676255

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

Toll-like receptor

P932

3771346

http://www.w3.org/2001/XMLSchema#string